The relationship between receptor-effector unit heterogeneity and the shape of the concentration-effect profile: Pharmacodynamic implications Amnon HoffmanAssaf Goldberg OriginalPaper 17 January 1995 Pages: 449 - 468
Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking Mark A. MiladElizabeth A. LudwigWilliam J. Jusko OriginalPaper 18 January 1995 Pages: 469 - 480
Pharmacokinetics of bupivacaine enantiomers in sheep: Influence of dosage regimen and study design Laurence E. MatherAlbert J. RuttenJohn L. Plummer OriginalPaper 25 January 1995 Pages: 481 - 498
Pharmacodynamic analysis of hematologic profiles Gary L. RosnerPeter Müller OriginalPaper 15 March 1995 Pages: 499 - 524
Comparison of some control strategies for three-compartment PK/PD models Chuanpu HuWilliam S. LovejoySteven L. Shafer OriginalPaper 18 January 1995 Pages: 525 - 550
Measuring switchability and prescribability: When is average bioequivalence sufficient? Walter W. HauckSharon Anderson OriginalPaper 28 December 1994 Pages: 551 - 564
Simple approximate formulas for calculating the time to clear drug and the time to accumulate drug when the plasma disposition curve of the drug is multiexponential Dennis A. Noe Letter to the Editor 28 February 1995 Pages: 565 - 567